A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
Sponsored by Aridis Pharmaceuticals, Inc.
About this trial
Last updated 2 years ago
Study ID
AR-320-003
Status
Recruiting
Type
Interventional
Phase
Phase 3
Placebo
Yes
Accepting
12 to 65 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended a year ago
What is this trial about?
Clinical trial looking at safety and efficacy of suvratoxumab in prevention of pneumonia
caused by Staphylococcus aureus in high-risk patients
What are the participation requirements?
Inclusion Criteria
1. Colonized with Staphylococcus aureus;
2. Expected to require prolonged intubation and mechanical ventilation, without any evidence of active pneumonia.
Exclusion Criteria
1. Staphylococcal disease at randomisation;
2. Lung injury score consistent with pneumonia;
3. Chronic tracheostomy patients;
4. The study subject is moribund
5. Receipt of anti- S. aureus systemic antibiotics
6. Active pulmonary disease